TSG Partners' CEO and Managing Partner, Panna Sharma, to speak at 2007 NUTRACON Europe Conference
June 14, 2007 (PRLEAP.COM) Health NewsTSG Partners today announced that Panna Sharma, CEO and Managing Partner of TSG, will be speaking at the 2007 NUTRACON European Conference in London, UK.
Sharma will be speaking on the topic of valuation and deal trends and what is driving the capital markets landscape in the high growth area of Nutrasciences. Mergers, acquisitions, buy-outs and sector consolidations are happening all around on a pan-European and global basis. TSG Partners expects deal opportunities to continue to accelerate over the coming quarters. Sharma will provide a unique capital market perspective for the nutraceutical industries for the coming two years.
NUTRACON Europe 2007 is Europe’s foremost conference on food supplements, sports nutrition, beauty innovations, market opportunities and market regulation. This market-relevant high level conference will offer significant commercial information about emerging market opportunities, regulatory information and its effects on current and future market development and insights into new innovations.
Key conference topics will include opportunities in emerging markets such as Turkey and Russia, supply chain management focused on China, growth and market trends in sports nutrition and supplements, latest studies and consumer applications in Nutrigenomics, and the huge potential in Nanotechnology for the nutraceuticals sector.
Key conference speakers will include Grant Ferrier, Editor of Nutrition Business Journal; Richard Ross, Legislation & Procedural Affairs Director of GlaxoSmithKline; Kathleen Mullinex, CEO of WellGen, Inc.; and Panna Sharma, CEO and Managing Partner of TSG Partners.
This year’s NUTRACON Europe conference will be held on Thursday, June 14th to Friday, June 15th at One Whitehall Place linked to The Royal Horseguards Hotel in London, UK.
About TSG Partners
TSG Partners is a specialty advisory group that combines corporate strategy and corporate finance to create shareholder value for companies and investors in the life sciences, biotechnology, healthcare and wellness sectors. TSG’s approach is based on a combination of independent analysis of the markets and customer needs, a deep appreciation of the technology landscape, operational plans that are defensible and stress-tested, and the capital markets environment. TSG’s focus on growth aims at developing a holistic approach that takes into account internal efforts, alliances, collaborations and strategic transaction opportunities. TSG Partners has presence in Atlanta, Boston and Silicon Valley.